split semaglutide dose twice a week Dosing Weekly: Safety & Efficacy Semaglutide and Tirzepatide Dosage Charts:

Adverse Reactions in Clinical Trials in Adults with Obesity or Overweight for Weight Reduction WEGOVY 2.4 mg Subcutaneous Injection Weekly Dosage WEGOVY was evaluated for safety in 3 randomized, double-blind, placebo-controlled trials that included 2,116 adult patients with obesity or overweight treated with 2.4 mg WEGOVY injection for up to 68 weeks and a 7-week off-drug follow-up period [see Clinical Studies (14.2)]

Oral-Specific Precautions Place the tablet under the tongue and allow it to fully dissolve do not chew or swallow whole Avoid eating or drinking for at least 30 minutes after administration to ensure proper absorption Oral semaglutide absorption can be variable

You should never increase a dose if you are not tolerating it well

medical societies, offering structured approaches to follow up care, lifestyle planning, and long term weight management

Ottney A